bay-11-7082 and Diabetic-Cardiomyopathies

bay-11-7082 has been researched along with Diabetic-Cardiomyopathies* in 1 studies

Other Studies

1 other study(ies) available for bay-11-7082 and Diabetic-Cardiomyopathies

Article	Year
Catalase ameliorates diabetes-induced cardiac injury through reduced p65/RelA- mediated transcription of BECN1. Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:12 Catalase is an antioxidative enzyme that converts hydrogen peroxide (H Topics: Animals; Apoptosis; Autophagy; Beclin-1; Catalase; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucose; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Myocytes, Cardiac; Nitriles; RNA, Small Interfering; Signal Transduction; Streptozocin; Sulfones; Transcription Factor RelA; Transcription, Genetic	2017

Article

Year

Catalase ameliorates diabetes-induced cardiac injury through reduced p65/RelA- mediated transcription of BECN1.

Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:12

Catalase is an antioxidative enzyme that converts hydrogen peroxide (H

Topics: Animals; Apoptosis; Autophagy; Beclin-1; Catalase; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucose; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Myocytes, Cardiac; Nitriles; RNA, Small Interfering; Signal Transduction; Streptozocin; Sulfones; Transcription Factor RelA; Transcription, Genetic

2017